Post-Doctoral Fellow

Location
Houston, Texas (US)
Salary
Competitive
Posted
April 26 2021
Position Type
Full Time
Organization Type
Healthcare/Hospital

Opening for Postdoctoral Fellow Position at MD Anderson Cancer Center

A full-time postdoctoral fellow position is available in Dr. Wenyi Wang’s lab, at the Department of Bioinformatics and Computational Biology at the University of Texas MD Anderson Cancer Center. Dr. Wang’s laboratory performs research aiming to gain new knowledge in the evolution of the human genome as well as the cancer genome. These two topics are fundamental to the understanding of the initiation, progression and treatment of human diseases. Currently her laboratory is focused on two research directions: 1) Development of deconvolution models in order to build an atlas of gene expression states of tumor and immune cells during cancer evolution; and 2) Statistical models for cancer risk counseling for individuals with deleterious germline mutations. For further information, visit the lab website at  

https://odin.mdacc.tmc.edu/~wwang7/.

The postdoctoral fellow position is a full-time, 12-month. The selected candidate will join the research programs in tumor heterogeneity and evolution, as well as the human cell atlas network.

The proposed start date is June 1, 2021. The postdoctoral fellow will be mentored directly by Dr. Wang, with possible co-mentorship from clinicians and cancer biologists in thyroid or prostate cancer. Applications will be accepted until the position is filled.

Position Qualifications

A Ph.D. degree in bioinformatics, biomedical engineering, systems biology, physics or any related field in life science. Extensive experience in computational biology and cancer biology is required.

To apply, send a curriculum vitae, a research statement and three references titled “Postdoctoral application - Name” to wwang7@mdanderson.org.

Salary – competitive.

It is the policy of The University of Texas MD Anderson Cancer Center to provide equal employment opportunity without regard to race, color, religion, age, national origin, sex, gender, sexual orientation, gender identity/expression, disability, protected veteran status, genetic information, or any other basis protected by institutional policy or by federal, state or local laws unless such distinction is required by law. http://www.mdanderson.org/about-us/legal-and-policy/legal-statements/eeo-affirmative-action.html

About MD Anderson
The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution's sole mission is to end cancer for patients and their families around the world. MD Anderson is one of only 51 comprehensive cancer centers designated by the National Cancer Institute (NCI). MD Anderson is ranked No. 1 for cancer care in U.S. News & World Report's Best Hospitals survey. It has ranked as one of the nation's top two hospitals for cancer care since the survey began in 1990, and has ranked first 16 times in the last 19 years. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).